CUSIP: 78472W104
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,559,387
-
Share change
-
+1,775,706
-
Total reported value
-
$195,925,517
-
Price per share
-
$14.45
-
Number of holders
-
48
-
Value change
-
+$27,609,195
-
Number of buys
-
36
-
Number of sells
-
14
Quarterly Holders Quick Answers
What is CUSIP 78472W104?
CUSIP 78472W104 identifies SQZB - SQZ BIOTECHNOLOGIES CO - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2021
-
Previous quarter:
Q1 2021
Recent filing periods for CUSIP 78472W104:
Institutional Holders of SQZ BIOTECHNOLOGIES CO - COM (SQZB) as of Q2 2021
As of 30 Jun 2021,
SQZ BIOTECHNOLOGIES CO - COM (SQZB) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,559,387 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, AMERICAN INTERNATIONAL GROUP, INC., Artal Group S.A., 683 Capital Management, LLC, BlackRock Inc., MAVERICK CAPITAL LTD, VANGUARD GROUP INC, LUMINUS MANAGEMENT LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.